Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization

被引:150
作者
Chen, Xianfeng [1 ]
Fernando, Germain J. P. [1 ]
Crichton, Michael L. [1 ]
Flaim, Christopher [1 ]
Yukiko, Sally R. [1 ]
Fairmaid, Emily J. [2 ]
Corbett, Holly J. [1 ]
Primiero, Clare A. [1 ]
Ansaldo, Alexander B. [1 ]
Frazer, Ian H. [3 ]
Brown, Lorena E. [2 ]
Kendall, Mark A. F. [1 ,3 ]
机构
[1] Univ Queensland, Delivery Drugs & Genes Grp D2G2, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia
[2] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia
[3] Univ Queensland, Diamantina Inst, Brisbane, Qld 4102, Australia
基金
比尔及梅琳达.盖茨基金会; 澳大利亚研究理事会; 英国医学研究理事会;
关键词
Microprojection; Vaccine coating; Thermostability; BALLISTIC DELIVERY; LANGERHANS CELLS; TRANSDERMAL DELIVERY; DNA VACCINE; SKIN; ELECTROPORATION; PENETRATION; MICROPARTICLES; FORMULATIONS; MICRONEEDLES;
D O I
10.1016/j.jconrel.2011.02.026
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Dry-coated microprojections can deliver vaccine to abundant antigen-presenting cells in the skin and induce efficient immune responses and the dry-coated vaccines are expected to be thermostable at elevated temperatures. In this paper, we show that we have dramatically improved our previously reported gas-jet drying coating method and greatly increased the delivery efficiency of coating from patch to skin to from 6.5% to 32.5%, by both varying the coating parameters and removing the patch edge. Combined with our previous dose sparing report of influenza vaccine delivery in a mouse model, the results show that we now achieve equivalent protective immune responses as intramuscular injection (with the needle and syringe), but with only 1/30th of the actual dose. We also show that influenza vaccine coated microprojection patches are stable for at least 6 months at 23 degrees C. inducing comparable immunogenicity with freshly coated patches. The dry-coated microprojection patches thus have key and unique attributes in ultimately meeting the medical need in certain low-resource regions with low vaccine affordability and difficulty in maintaining "cold-chain" for vaccine storage and transport. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:349 / 355
页数:7
相关论文
共 52 条
[1]   Introducing HPV vaccine in developing countries - Key challenges and issues [J].
Agosti, Jan M. ;
Goldie, Sue J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19) :1908-1910
[2]   Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines [J].
Alarcon, Jason B. ;
Hartley, Andrea Waterston ;
Harvey, Noel G. ;
Mikszta, John A. .
CLINICAL AND VACCINE IMMUNOLOGY, 2007, 14 (04) :375-381
[3]   Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate Glass [J].
Alcock, Robert ;
Cottingham, Matthew G. ;
Rollier, Christine S. ;
Furze, Julie ;
De Costa, Samodh D. ;
Hanlon, Marian ;
Spencer, Alexandra J. ;
Honeycutt, Jared D. ;
Wyllie, David H. ;
Gilbert, Sarah C. ;
Bregu, Migena ;
Hill, Adrian V. S. .
SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (19) :19ra12
[4]   Development of stable influenza vaccine powder formulations: Challenges and possibilities [J].
Amorij, J-P. ;
Huckriede, A. ;
Wischut, J. ;
Frijlink, H. W. ;
Hinrichs, W. L. J. .
PHARMACEUTICAL RESEARCH, 2008, 25 (06) :1256-1273
[5]  
[Anonymous], WORLD HLTH REPORT
[6]   Status of terpenes as skin penetration enhancers [J].
Aqil, Mohammed ;
Ahad, Abdul ;
Sultana, Vasmin ;
Ali, Asgar .
DRUG DISCOVERY TODAY, 2007, 12 (23-24) :1061-1067
[7]   Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery [J].
Babiuk, S ;
Baca-Estrada, M ;
Babiuk, LA ;
Ewen, C ;
Foldvari, M .
JOURNAL OF CONTROLLED RELEASE, 2000, 66 (2-3) :199-214
[8]   Pig and guinea pig skin as surrogates for human in vitro penetration studies: A quantitative review [J].
Barbero, Ana M. ;
Frasch, H. Frederick .
TOXICOLOGY IN VITRO, 2009, 23 (01) :1-13
[9]   UNUSUAL NUMBERS AND DISTRIBUTIONS OF LANGERHANS CELLS IN SKIN WITH UNIQUE IMMUNOLOGICAL PROPERTIES [J].
BERGSTRESSER, PR ;
TOEWS, GB ;
GILLIAM, JN ;
STREILEIN, JW .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1980, 74 (05) :312-314
[10]   Characterization of a thermostable hepatitis B vaccine formulation [J].
Braun, LaToya Jones ;
Jezek, Jan ;
Peterson, Sabrina ;
Tyagi, Anil ;
Perkins, Shalimar ;
Sylvester, David ;
Guy, Mark ;
Lal, Manjari ;
Priddy, Scott ;
Plzak, Heidi ;
Kristensen, Debra ;
Chen, Dexiang .
VACCINE, 2009, 27 (34) :4609-4614